Osteopontin stimulates a subpopulation of quiescent human prostate epithelial cells with high proliferative potential to divide in vitro

Prostate

Volumn 35, Issue 2, 1998, Pages 83-94

  Elgavish, Ada ^a   Prince, Charles ^a   Chang, Pi Ling ^a   Lloyd, Keith ^a   Lindsey, Russell ^a   Reed, Rebecca ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Adhesion; Epithelial cells; Integrin; Osteopontin; Proliferation; Prostate

Indexed keywords

COLLAGEN; FIBRONECTIN; GROWTH FACTOR; INTEGRIN; OSTEOPONTIN;

ARTICLE; CELL ADHESION; CELL GROWTH; CELL PROLIFERATION; CELL SUBPOPULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA;

CELL ADHESION; CELL DIVISION; CELLS, CULTURED; EPITHELIAL CELLS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MALE; MICROSCOPY, ELECTRON; OSTEOPONTIN; PROSTATE; SIALOGLYCOPROTEINS;

EID: 0031897428     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19980501)35:2<83::AID-PROS1>3.0.CO;2-H     Document Type: Article

References (61)

1. Boring CC, Squires TS, Tong T: Cancer statistics. CA Cancer J Clin 1991;41:19-36.
2. Steiner MS: Role of peptide growth factors in the prostate: A review. Urology 1993;42:99-110.
3. Tenniswood MP, Montpetit ML, Leger JG, Wong P, Pineault JM, Rouleau M: Epithelial-stromal interactions and cell death in the prostate. In Farnsworth WE, Ablin RJ (eds): "The Prostate as an Endocrine Gland." Boca Raton: CRC Press, 1990:187-207.
4. Chirado A: National Cancer Institute roundtable on prostate cancer: Future research directions. Cancer Res 1991;51:2498-2505.
5. Maygarden SJ: Applications of immunohistochemistry to the diagnosis and prognostication of prostate carcinoma and prostatic intraepithelial neoplasia. Pathol Annu 1994;29:303-320.
6. Mostofi FK, Sesterhenn IA, Davis CJ: A pathologist's view of prostatic carcinoma. Cancer 1993;71:906-932.
7. Brawer MK: Prostatic intraepithelial neoplasia: A premalignant lesion. J Cell Biochem 1992;16:171-174.
8. Berger RE, Krieger JN, Rothman I, Muller CH, Hillier SL: Bacteria in the prostate tissue of men with idiopathic prostatic inflammation. J Urol 1997;157:863-865.
9. El-Demiry MIM, Hargreave TB, Busittil A, Ritchie JK, Chisholm GD: Lymphocyte subpopulations in the male genital tract. Br J Urol 1985;57:769.
10. McClinton S, Miller ID, Eremin O: An immunohistochemical characterization of the inflammatory cell infiltrate in benign and malignant prostatic disease. Br J Cancer 1990;61:400-403.
11. Patarca R, Saavedra RA, Cantor H: Molecular and cellular basis of genetic resistance to bacterial infection: The role of the early T-lymphocyte activation-1/osteopontin gene. CRC Crit Rev Immunol 1993;13:225-246.
12. Denhardt DT, Guo X: Osteopontin: A protein with diverse functions. FASEB J 1993;7:1475-1482.
13. Brown LF, Berse B, Van De Water L, Papadopoulos-Sergiou A, Peruzzi CA, Manseau EJ, Dvorak HF, Senger DR: Expression and distribution of osteopontin in human tissues: Widespread association with luminal epithelial surfaces. Mol Biol Cell 1992; 3:1169-1180.
14. Brown LF, Papadopoulos-Sergiou A, Berse B, Manseau EJ, Tognazzi K, Perruzzi CA, Dvorak HF, Senger DR: Osteopontin expression and distribution in human carcinomas. Am J Pathol 1994;145:610-623.
15. Reznikoff CA, Swaminathan S, Verma AK: Cultured normal human epithelial cells: A new system for in vitro carcinogenesis studies. In Webber MM, Sekely LI (eds): "In Vitro Models for Cancer Research," Vol IV. Boca Raton: CRC Press, 1986:63-101.
16. Elgavish A, Wille JJ, Rahemtulla F, Debro L: Carrier-mediated sulfate transport in human ureteral epithelial cells cultured in serum-free medium. Am J Physiol 1991;261:916-926.
17. Wille JJ, Park J, Elgavish A: Effects of growth factors, hormones, bacterial LPS and LTs on the clonal growth of normal ureteral epithelial cells in serum-free culture. J Cell Physiol 1992;150:52-58.
18. Elgavish A: Effects of Escherichia coli adhesion and E. coli lipopolysaccharides on the function of human ureteral epithelial cells cultures in serum-free medium. Infect Immun 1993;61: 3304-3312.
19. Elgavish A, Pattanaik A, Lloyd K, Reed R: Integrin-mediated adhesive properties of uroepithelial cells are inhibited by treatment with bacterial toxins. Am J Physiol 1994;266:1552-1559.
20. Elgavish A, Lloyd K, Reed R: I. A subpopulation of human urothelial cells is stimulated to proliferate by treatment in vitro with lipoteichoic acid, a cell wall component of Streptococcus faecalis. J Cell Physiol 1996;169:42-51.
21. 1 integrins in human urothelial cells. J Cell Physiol 1996;169:52-65.
22. Elgavish A, Robert B, Lloyd K, Reed R: III. Nitric oxide mediates the action of lipoteichoic acid on the function of human urothelial cells. J Cell Physiol 1996;169:66-77.
23. Peehl DM, Stamey TA: Serum-free growth of adult human prostatic epithelial cells. In Vitro Cell Dev Biol 1986;22:82-90.
24. Shipley GD, Hamm RG: Improved medium and culture conditions for clonal growth with minimal serum protein and for enhanced serum-free survival of Swiss 3T3 cells. In Vitro 1981; 17:656-670.
25. Tsao MC, Walthall BJ, Hamm RG: Clonal growth of normal human epidermal keratinocytes in a defined medium. J Cell Physiol 1982;110:219-229.
26. Ingber DE: Fibronectin controls capillary endothelial cell growth by modulating cell shape. Proc Natl Acad Sci USA 1990; 87:3579-3583.
27. Folkvord JM, Viders D, Coleman-Smith A, Clark RA: Optimization of immunohistochemical techniques to detect extracellular matrix proteins in fixed skin specimens. J Histochem Cytochem 1989;37:105-113.
28. Sheehan D, Hrapchak BB: "Theory and Practice of Histotechnology," St. Louis: C.V. Mosby Co., 1980.
29. Magaud JP, Sargent I, Clarke PJ, Ferench M, Rimokh R, Mason, DY: Double immunohistochemical labeling of cell and tissue samples with monoclonal antibromodeoxyuridine. J Histochem Cytochem 1989;37:1517-1527.
30. Potten CS, Morris RJ: Epithelial stem cells in vivo. J Cell Sci [Suppl] 1988;10:45-62.
31. Potten CS, Loeffler M: Stem cells: Attributes, cycles, spirals, pitfalls and uncertainties. Development 1990;110:1001-1020.
32. Issacs JT: Control of cell proliferation and cell death in the normal and neoplastic prostate: A stem cell model. In Rodgers CH, Coffey DS, Cunha G, Grayhack JT, Hinman F, Horton R (eds): "Benign Prostatic Hyperplasia," Washington, DC: US Department of Health and Human Services NIH Publication #87, 1987: 2881.
33. Kinbara H, Cunha GR, Boutin E, Hayashi N, Kawamura J: Evidence of stem cells in the adult prostatic epithelium based upon responsiveness to mesenchymal inductors. Prostate 1996;29: 107-116.
34. Bonkhoff H, Remberger K: Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: A stem cell model. Prostate 1996;28:98-106.
35. Bonkhoff H, Stein U, Remberger K: Multidirectional differentiation in the normal, hyperplastic and neoplastic human prostate: Simultaneous demonstration of cell-specific epithelial markers. Hum Pathol 1994;25:42-16.
36. Montironi R, Bostwick DG, Bonkhoff H, Cockett AT, Helpap B, Troncoso P, Waters D: Origins of prostate cancer. Cancer 1996; 78:362-365.
37. Xuan JW, Hota C, Chambers AF: Recombinant GST-human osteopontin fusion protein is functional in RGD-dependent cell adhesion. J Cell Biochem 1994;54:247-255.
38. Gadeau AP, Campan M, Millet D, Candresse T, Desgranges C: Osteopontin overexpression is associated with arterial smooth muscle cell proliferation in vitro. Atheroscler Thromb 1993;13: 120-125.
39. Hwang S-M, Lopez CA, Heck DE, Gardner CR, Laskin DL, Laskin JD, Denhardt DT: Osteopontin inhibits induction of nitric oxide synthase gene expression by inflammatory mediators in mouse kidney epithelial cells. J Biol Chem 1994;269:711-715.
40. Miyauchi A, Alvarez J, Greenfield EM, Teti A, Grano M, Colucci S, Zambonin-Zallone A, Ross FP, Teitelbaum SL, Cheresh D: Recognition of osteopontin and related peptides by an alpha v beta 3 integrin stimulates immediate cell signals in osteoclasts. J Biol Chem 1991;266:20269-20374.
41. i in rat osteoclasts and mouse-derived osteoclast-like cells. Am J Physiol 1994;266:376-381.
42. Giachelli CM, Liaw L, Murry CE, Schwartz SM, Almeida M: Osteopontin expression in cardiovascular diseases. Ann NY Acad Sci 1995;760:109-126.
43. Liaw L, Skinner MP, Raines EW, Ross R, Cheresh DA, Schwartz SM, Giachelli CM: The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro. J Clin Invest 1995;95:713-724.
44. Witkowski CM, Rabinovitz I, Nagle RB, Affinito K-S, Cress AE: Characterization of integrin subunits, cellular adhesion and tumorigenicity of four human prostate cell lines. J Cancer Res Clin Oncol 1993;119:637-644.
45. 3 subunit. Exp Cell Res 1992;203:270-275.
46. Hynes RO: Integrins: A family of cell surface receptors. Cell 1992;69:11-25.
47. Ruoslahti E, Pierschbacher MD: Integrins as receptors for extracellular matrix. Science 1987;238:491-497.
48. Zetter BR, Chackal-Roy M, Smith R: The cellular basis for prostate cancer metastasis. In Karr JP, Yamanaka H (eds): "Prostate Cancer Bone Metastasis," New York: Plenum Press, 1990:39-44.
49. Chackal Rossi M, Zetter BR: Selective stimulation of prostatic carcinoma cell proliferation by transferrin. Proc Natl Acad Sci USA 1992;89:6197-6201.
50. Gleave M, Hsieh J-T, Gao C, von Eschenbach AC, Chung LWK: Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Cancer Res 1991;51: 3753-3761.
51. Gleave M, Hsieh J-T, Gao C, von Eschenbach AC, Chung LWK: Prostate and bone fibroblasts induce human prostate cancer growth in vivo: Implications for bidirectional tumor-stromal cell interaction in prostate carcinoma growth and metastasis. J Urol 1992;147:1151-1159.
52. Chung LWK, Li W, Gleave ME, Hsieh J-T, Wu H-C, Sikes RA, Zhau HE, Bandyk MG, Logothetis CJ, Rubin JS, von Eschenbach AC: Human prostate cancer model: Roles of growth factors and extracellular matrices. J Cell Biochem [Suppl] 1992;16:99-105.
53. Ware J: Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer. Cancer Metastasis Rev 1993;12:287-301.
54. Moll R, Franke WW, Schiller DL: The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982;31:11-24.
55. Morrison SJ, Shah NM, Anderson DJ: Regulatory mechanisms in stem cell biology. Cell 1997;88:287-298.
56. Weber GF, Ashkar S, Glimcher MJ, Cantor H: Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 1996; 271:509-512.
57. Rudzki Z, Jothy S: CD44 and the adhesion of neoplastic cells. J Clin Pathol Mol Pathol 1997;50:57-71.
58. Naor D, Sionov RV, Ish-Shalom D: CD44: Structure, function, and association with the malignant process. Adv Cancer Res 1997;71:241-319.
59. Stevens JW, Palachek PL, Griebling TL, Midura RJ, Rokhlin OW, Cohen MB: Expression of CD44 isoforms in human prostate tumor cell lines. Prostate 1996;28:153-161.
60. Nagabushan M, Pretlow TG, Guo Y-J, Amini SB, Pretlow TP, Sy M-S: Altered expression of CD44 in human prostate cancer during progression. Am J Clin Pathol 1996;106:647-651.
61. Weber GF, Ashkar S, Cantor H: Interaction between CD44 and osteopontin as a potential basis for metastasis formation. Proc Assoc Am Phys 1997;109:1-9.